Arjo extend joint marketing agreement with BBI to Northern & Southern Ireland

In August 2018 Arjo and BBI (Europe) Ltd (Bruin Biometrics) signed a Joint Marketing Agreement allowing both companies to work together for the promotion of a Pressure Ulcer (PU) Prevention Solution Set combining the BBI SEM 200 Scanner and Arjo pressure ulcer interventions, including specialised beds, therapeutic surfaces and patient mobility equipment, resulting in an offering that provides real preventive healthcare for those at risk of pressure ulcers.

arjo bruin bbi pressure ulcer

Following a review of that agreement we agreed that, due to the success achieved so far, the JMA territory will be expanded to include Northern & Southern Ireland.

“Arjo has a long, proud and successful record in bringing innovative and new solutions to both NHS & HSE together with Private; Long Term Care and Homecare providers. The ability to extend our work with BBI (Europe) Ltd allows us to progress our shared goal of reducing pressure ulcers.” says William Dorrian, Director, Arjo Corporate Development & Projects.

Arjo’s Pressure Ulcer & Injury Prevention Solutions enable healthcare professionals to effectively prevent and treat pressure ulcers.  Our offering, including an integrated clinical approach, products, business models and aftermarket support improves patient outcomes and reduces healthcare costs.

The SEM 200 Scanner is a wireless hand-held device that objectively alerts clinicians to specific anatomical areas of a patient’s body at increased risk of pressure ulcers. The SEM 200 Scanner supports clinicians, as an adjunct to current standard of care, to identify these areas of increased risk of pressure ulcer development 5 days (median)1earlier than visual skin assessment.

Colin Priestley, MD EMEA BBI (Europe) Ltd stated, “BBI is delighted to continue and broaden our work with Arjo, a recognised health care solutions provider.  This agreement, incorporating the innovative technology of the SEM 200 Scanner, will enable healthcare practitioners across the UK & Ireland to further develop their prevention protocols as they continue to strive for pressure ulcer incidence reduction”.

The extension to the Joint Marketing Agreement will commence with immediate effect.

For further information, please contact:

For Arjo

Martyn Elcocks, Strategic Marketing Director, UKI
Tel: +44 1582 745575


Kate Hancock, VP Marketing and Clinical Communications, North America and EMEA
Tel: +44 7827 315347


1. Okonkwo H. Milne J. et al. (2018) Evaluation of a novel device using capacitance of the detection of early pressure ulcers (PU), a multi-site longitudinal study. Accepted and presented at NPUAP 2018